Canada Pension Plan Investment Board’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$320K Buy
189,100
+45,000
+31% +$92.6K ﹤0.01% 1399
2025
Q4
$285K Buy
+144,100
New +$461K ﹤0.01% 1536
2025
Q1
Sell
-4,500
Closed -$10.6K 1459
2024
Q4
$10.6K Buy
+4,500
New +$79K ﹤0.01% 1372
2014
Q2
Sell
-400
Closed -$15K 1288
2014
Q1
$15K Buy
+400
New +$14.1K ﹤0.01% 1256

Other funds holding FLNA

Canada Pension Plan Investment Board's FLNA Position: Q1 2026 in Review

Canada Pension Plan Investment Board increased its Filana Therapeutics (FLNA) stake by 31% in Q1 2026, buying an estimated $92.6K and bringing the position to 189,100 shares worth $320K. The position accounts for ﹤0.01% of the portfolio, ranked #1399.

Canada Pension Plan Investment Board first reported a position in FLNA in Q1 2014 and has held it in 4 quarters since. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Canada Pension Plan Investment Board held 189,100 shares of Filana Therapeutics worth $320K as of Q1 2026.
  • Canada Pension Plan Investment Board bought 45,000 Filana Therapeutics shares in Q1 2026, an estimated $92.6K.
  • Filana Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1399 holding.
  • Canada Pension Plan Investment Board first reported a position in Filana Therapeutics in Q1 2014 and has held it in 4 quarters since.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.